Quant Flexi Cap Fund
The scheme seeks to generate consistent returns by investing in portfolio of Large Cap, Mid Cap and Small Cap Companies.
Growthvine rating: 3/5 — ranked #25 of 56 in category.
Fund basics
| Category | Equity: Flexi Cap |
|---|
| NAV | ₹99.63 (as of 2026-10-22) |
|---|
| AUM | ₹7,364 Cr |
|---|
| Expense ratio | 1.54% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Ayusha Kumbhat |
|---|
| Exit load | 1% for redemption within 15 days |
|---|
Performance & risk
| 5-year annualised return | 12.43% |
|---|
| Sharpe ratio | 0.46 |
|---|
| Standard deviation | 19.36% |
|---|
| Max drawdown | −59.53% |
|---|
| Alpha | 3.93 |
|---|
| Beta | 1.11 |
|---|
Over 5 years, captured 114.9% of Nifty 500's upside and 97.8% of its downside.
Market cap allocation
| Large cap | 64.1% |
|---|
| Mid cap | 26.1% |
|---|
| Small cap | 9.8% |
|---|
Concentration
| Top 5 holdings | 38.6% |
|---|
| Top 10 holdings | 57.2% |
|---|
| Total holdings | 31 |
|---|
| Index overlap | 7.1% |
|---|
| Active share | 92.9% |
|---|
Top holdings
- TREPS 01-Oct-2026 DEPO 10 — 23.9%
- Samvardhana Motherson International Limited — 9.3%
- Adani Enterprises Ltd. — 8.1%
- Adani Power Limited — 8.0%
- Aurobindo Pharma Ltd. — 6.9%
- ICICI Prudential Asset Management Company Limited — 6.4%
- Reliance Industries Ltd. — 4.9%
- Adani Green Energy Limited — 3.7%
- Glenmark Pharmaceuticals Ltd. — 3.4%
- Tata Power Co. Ltd. — 3.4%
Top sectors
- Energy — 17.8%
- Derivatives — 15.5%
- Pharma & Biotech — 11.7%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | 0.6% | Q1 (Top) | #8 of 50 |
| 2025 | 3.3% | Q3 | #25 of 43 |
| 2024 | 15.3% | Q3 | #32 of 42 |
| 2023 | 29.8% | Q2 | #14 of 36 |
| 2022 | 11.1% | Q1 (Top) | #2 of 30 |